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a-Bungarotoxin (a-BuTx) was isolated from the venom of the Fonuosan banded krait (Bungarus multicinc- 
tus). The amino acid sequence was determined by a combination of conventional methods. In contrast to 
the sequence of a-BuTx reported by Mebs et al. [(1971) Biochem. Biophys. Res. Commun. 44, 711-7161, 
our results revealed the presence of Ser-Pro-I&, Pro-His and Gln-4 at positions 9-l 1, 67-68 and 7 l-72 - -- - 
from the amino-terminal, respectively, and not I&-Pro-Ser, His-Pro and Arg-Gln as reported previously. --- 
a-Bungarotoxin; Amino acid sequence; Neurotoxin; Acetylcholine r ceptor; (Bungarus) 
1. INTRODUCTION 
Venoms from snakes belonging to the families 
Elapidae (cobras, mumbas, tiger snakes, black 
snakes, taipan, etc.) and Hydrophidae (sea snakes) 
are highly toxic and produce flaccid paralysis and 
respiratory failure [2]. These proteins have been 
designated as neurotoxins, which are subdivided 
into two groups with respect o the mode of the in- 
hibitory action at the neuromuscular junction. 
Postsynaptic neurotoxins bind selectively to the 
nicotinic acetylcholine receptors (AChR) on the 
postsynaptic membrane at the neuromuscular 
junction. The primary structures of a number of 
postsynaptic neurotoxins [3,4] and the tertiary 
structures of some of them have been elucidated 
[5-81. 
In particular, cY-bungarotoxin (a-BuTx), a prin- 
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cipal protein isolated from the crude venom of the 
elapid snake (Bungarus multicinctus), has been 
most widely used in pharmacological and 
biochemical studies on the nicotinic AChR and as 
a diagnostic tool in the evaluation of anti-AChR 
antibody in myasthenia gravis [9]. The primary 
structure of this toxin was determined by Mebs et 
al. [ 11. In this report we determined the amino acid 
sequence of (Y-BuTx, and compared it with the se- 
quence reported previously. 
2. MATERIALS AND METHODS 
2.1. Isolation of a-BuTx from crude venom 
The lyophilized venom of B. multicinctus was 
obtained from the Miami Serpentarium (USA). cy- 
BuTx- was purified by one-step column 
chromatography on CM-Sephadex C-25 using a 
linear gradient from 0.05 M ammonium acetate 
(pH 5.8) to 1 M ammonium acetate buffer (pH 
7.0) as in [lo]. Each fraction obtained was desalted 
on a Sephadex G-25 column and lyophilized. Final 
purification of CZ-BuTx was achieved by reversed- 
phase HPLC on a Cosmosil 5C18 column 
(Nakarai, Japan) with 0.1% trifluoroacetic acid 
containing a linear gradient from 10 to 50% 
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acetonitrile. S-carboxymethylated (Cm) derivatives 
of cu-BuTx was prepared by the method of 
Crestfield et al. [l 11. 
quencer (model 470A) equipped with an on-line 
PTH-analyzer (model 120A). Polybrene was used 
as a carrier [13]. 
2.2. Fragmentation of Cm-wBuTx 
A 20 nmol sample of Cm+-BuTx was digested 
in 0.1 M Tris-acetate buffer (pH 8.5) at 37°C for 
2 h with 1% (w/w) lysyl endopeptidase [12], which 
was produced by Achromobacter lyticus (EC 
3.4.21.50) (Wako, Japan). The peptides thus ob- 
tained were separated by reversed-phase HPLC on 
a Cosmosil X18 column with a linear gradient 
from 0 to 60% acetonitrile containing 0.1% (v/v) 
trifluoroacetic acid (fig. 1). 
2.3. Amino acid sequence analysis 
Protein and peptides were automatically se- 
quenced by means of an Applied Biosystems se- 
2.4. Amino acid analysis 
Protein and peptide samples were hydrolyzed 
with 6 N HCI at 110°C for 24 h in evacuated seal- 
ed tubes. The amino acid compositions were deter- 
mined with an amino acid analyzer (Hitachi model 
L-8500). 
3. RESULTS AND DISCUSSION 
3.1. N-terminal sequence of a-BuTx 
More than 20 protein fractions containing a ma- 
jor postsynaptic neurotoxin (cu-BuTx) and 
presynaptic neurotoxins (#-BuTxs) were obtained 
by CM-Sephadex ion-exchange column chroma- 
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Fig.1. Chromatographic separation of the six peptides. The digest was applied to a Cosmosil X18 column, and the 
peptides were eluted with a linear gradient from 100% (v/v) solvent A to 40% solvent A/60% solvent B in 60 min. 
Solvent A: 0.1% trifluoroacetic acid in distilled water; solvent B: 0.1% trifluoroacetic acid in acetonitrile. (-) 
Absorbance (210 nm), (-- -) 070 solvent B. 
80 
Volume 222, number 1 FEBS LETTERS September 1987 
Table 1 
Amino acid compositions of the peptides digested with lysyl endopeptidase 
Amino acid Cm+BuTx L-l L-2 L-3 L-4 L-5 L-6 
Cm-cysteine 9.14 (10) 1.05 (1) 1.98 (2) 2.15 (2) 2.14 (2) 3.06 (3) 
Aspartic acid 4.19 (4) 1.10 (1) 1.07 (1) 1.04 (1) 1.03 (1) 
Threonine 6.61 (7) 1.84 (2) 0.94 (1) 3.69 (4) 
Serine 5.53 (6) 1.00 (1) 0.93 (1) 1.82 (2) 1.85 (2) 
Glutamic acid 5.20 (5) 1.09 (1) 2.11 (2) 1.00 (1) 1.00 (1) 
Proline 7.75 (8) 0.99 (1) 1.78 (2) 0.89 (2) 0.85 (1) 2.80 (3) 
Glycine 3.99 (4) 1.12 (1) 1.01 (1) 1.18 (1) 1.05 (1) 
Alanine 4.94 (5) 1.81 (2) 1.06 (1) 1.79 (2) 
Valine 3.83 (5) 0.87 (1) 1.21 (2) 1.23 (2) 
Methionine l.001) 0.72 (1) 
Isoleucine 1.41 (2) 1.12 (2) 
Leucine 1.82 (2) 0.97 (1) 0.88 (1) 
Tyrosine 1.90 (2) 0.64 (1) 0.75 (1) 
Phenylalanine 0.98 (1) 0.86 (1) 
Lysine 5.72 (6) l.001) 2.002) l.001) l.001) I.001) 
Histidine 2.11 (2) 0.95 (1) 0.98 (1) 
Arginine 2.98 (3) I&Q_(l) 0.91 (1) 0.92 (1) 
Tryptophan + (1) + (1) 
Yield (@IO) 74 72 69 77 57 72 
Position 71-74 65-70 52-64 39-51 27-38 l-26 
The value for the underlined amino acids was taken as 1 .O or 2.0. Numbers in parentheses represent he integers from 
sequence analysis. Tryptophan was determined spectrophotometrically 
tography. The yield of c~-BuTx was 15.8% of the 
crude venom. The amino acid composition of c~- 
BuTx is listed in table 1, and agrees with that of 
previous reports. The N-terminal sequence of LY- 
BuTx was determined to be the following: 
H-Ile-Val-X-His-Thr-Thr-Ala-Thr-Ser-Pro-Ile- 
Ser-Ala-Val-Thr-X-Pro-Pro-Gly-Glu-Asn-Leu-X- 
Tyr-Arg-Lys-Met-Trp-X-Asp-Ala-Phe-X-Ser-Ser- 
Arg-Gly-Lys-Val-Val-Glu-Leu-Gly-X-Ala-Ala- 
Thr-X-Pro---. 
We did not detect any PTH amino acid at position 
X and deduced X to be a Cys residue. The N- 
terminal sequence was identical with that of the 
previous report except for positions 9 and 11 
(---bPro-Ser_--). 
3.2. Amino acid compositions and sequences of 
the peptides from lysyl endopeptidase digest 
The lysyl endopeptidase digest of Cm+BuTx 
was separated by HPLC into 6 fragments, L-l-L-6 
(fig.l), and their amino acid compositions were 
determined (table 1). The value of valine in peptide 
L-4 and those of valine and isoleucine in peptide 
L-6 were remarkably low because of insufficient 
I’ L-6 :VCHTTAT&PISAVTCPPGENLCYR 
-L-5.-,L’A L-4-F - L-3 
:1FCSSRGKhVELGCAATCPSKKPYEEVTCC60 t 
61---_-j 
t 
+L-2 - J+L-’ -741 
STDKCNPHPkQEPG -_ 
Fig.2. Amino acid sequence of cu-bungarotoxin from Formosan krait venom (B. multicinctus). L refers to the lysyl 
endopeptidase peptides. Underlined residues differ from the sequence in the report of Mebs et al. [l]. 
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Table 2 
Amino acid sequence of Cm+BuTx 
Peptide no. Sequence 
L-l Gin-Arg-Pro-Gly 
L-2 Cys-Am-Pro-His-Pro-Lys 
L-3 Lys-Pro-Tyr-Glu-Glu-Val-Thr-Cys-Cys-Ser-Thr-Asp-Lys 
L-4 Val-Val-Glu-Leu-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ser-Lys 
L-5 Met-Trp-Cys-Asp-Ala-Phe-Cys-Ser-Ser-Arg-Gly-Lys 
L-6 Ile-Val-Cys-His-Thr-Thr-Ala-Thr-Ser-Pro-Ile-Ser-Ala- 
Val-Thr-Cys-Pro-Pro-Gly-Glu-Asn-Leu-Cys-Tyr-Arg-Lys 
Right-handed arrows indicate that the sequence was elucidated by automated 
Edman degradation 
hydrolysis of the peptide bond of Val-Val (L-4) 
and Ile-Val (L-6) under standard conditions. Their 
sequences on 6 peptides from L-l to L-6 are sum- 
marized in table 2. Five peptides, except L-l, con- 
tained one or two lysyl residues. This means that 
the enzyme hydrolyzes specifically the carbbxy- 
terminal peptide bond of lysine residues. When the 
amino acid compositions and sequences of these 6 
peptides were compared with previous reports, dif- 
ferent amino acid sequences were observed in the 
three peptides, L-l (Gln-Arg-Pro-Gly), L-4 (Cys- 
Asn-Pro-His-Pro-Lys) and L-6 (Ile-Val----Ser_ 
Pro-I&----Arg-Lys) at positions 71-72, 67-68, and 
9 and 11, respectively. In spite of the identical 
amino acid composition the reported sequence 
contained ‘reversed sequences’ within each pep- 
tide. The amino acid sequence of cu-BuTx is shown 
in fig.2, in which the underlined residues differ 
from those in the previous report. This revised se- 
quence of c~-BuTx has a higher degree of homology 
of the C-terminal sequence of the iVaja naja oxiana 
neurotoxin I [14] than the unrevised sequence. 
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